Introduction
Uterine concentrations of the oxytocin receptor rise at luteolysis in sheep (Roberts et ai, 1976) , but despite simultaneous measurements of circulating progesterone and the receptor it has not been possible to determine whether the rise in receptor precedes or follows luteal regression (Sheldrick & Flint, 1985) . It is not known therefore whether induction of the oxytocin receptor causes the fall in circulating progesterone concentration at luteolysis or results from it. Evidence that it may play a causative role includes the fact that uterine secretion of prostaglandin (PG) F-2a, the luteolysin, is stimulated by oxytocin (Sharma & Fitzpatrick, 1974; Mitchell et ai, 1975) , presumably through interaction with the oxytocin receptor.
Oestradiol-17ß given during the mid-luteal phase of the oestrous cycle causes luteolysis in sheep and cattle (Brunner et ai, 1969; Bolt & Hawk, 1975; Hansel & Convey, 1983) and in rats and rabbits the oxytocin receptor is induced in uterine tissues after administration of oestradiol-17ß (Soloff, 1975; Nissenson et ai, 1978) . It is possible therefore that the luteolytic effect of oestradiol-17ß may be mediated through induction of the oxytocin receptor. The present experi¬ ments were undertaken to determine whether oestradiol-induced luteolysis is associated with raised *Reprint requests to Dr A. P. F. Flint. levels of the oxytocin receptor in sheep, and whether any such rise precedes or follows luteal regression and the fall in circulating progesterone. It was anticipated that the data obtained would improve our understanding both of the mechanism of the luteolytic effect of oestrogen and of the role of the oxytocin receptor in spontaneous luteolysis. Uterine phosphatidylinositol cycle activity was determined because its activation by oxytocin has been postulated to represent a source of arachidonic acid for synthesis of PGF-2a (Flint et ai, 1986 Seldinger (1953) . Catheters were inserted at least 24 h before starting to collect blood samples. Immediately after catheterization, and during sampling, the ewes were kept in metabolism cages under conditions that allowed blood to be obtained without disturbing the animals (Flint & Sheldrick, 1983) . The ewes were removed from the cages daily (usually between 12:15 and 13:00 h) for testing for oestrous behaviour with a vasectomized ram, which was housed in the same room as the ewes.
In Exp. 2, cyclic ewes were killed at intervals after administration of 750 pg oestradiol benzoate (given as in Exp. 1) for preparation of uterine oxytocin receptor and measurement of phosphatidylinositol turnover. Twelve animals were killed at 12,24, 36 or 48 h after the initial oestradiol treatment (3 at each time) and 9 vehicle-treated ewes were killed at 12:00 h on Days 9, 10 and 11 (3 on each day). To ensure that patterns of secretion after treatment were comparable to those observed in Exp. 1, all animals in Exp. 2 were sampled at 1-5 h intervals during the 12 h preceding slaughter, using the catheterization and blood sampling protocol described under Exp. 1.
To obtain uteri, the animals were killed by intravenous administration of a lethal dose of pentobarbitone sodium; tissues were collected onto ice and were dissected immediately.
Determination of uterine oxytocin receptor concentrations. Membrane fractions were prepared from caruncular and intercaruncular endometrium and from myometrium by homogenization in 25 mM-Tris-HCl, pH 7-6 containing 0-25 M-sucrose and 1 mM-EDTA followed by differential centrifugation as described by Sheldrick & Flint (1985 (Sheldrick & Flint, 1985) . With reverse-phase high-performance liquid chromatography to confirm the purity of the tracer, >90% of labelled material migrated with authentic oxytocin. As 02:C02 (95:5 v/v) and closed with a gas-tight stopper. Incubations were ended by removing the medium and homogenizing the slices in 10 ml unacidified chloroform-methanol (2:1, v/v). After separating the methanolic and chloroform phases by addition of 2 M-NaCl, and subsequently washing the chloroform extract 4 times with 2M-NaCl, the radioactivity incorporated into phosphatidylinositol was counted and expressed as d.p.m./g wet wt of slices (Flint et al, 1986) . All (1986) .
Radioimmunoassays. Progesterone was measured in plasma samples after extraction with diethyl ether as des¬ cribed by Sheldrick et al (1980) . Sensitivity of the assays reported here (calculated from 2 s.d. below the zero mass-added point) was equivalent to 0-12 ng/ml plasma. Intra-and inter-assay coefficients of variation were 7-4 and 91% respectively, and mean extraction recovery was 85-6 + 2-3%.
Oxytocin concentrations were determined after extraction with activated glass powder as validated by Sheldrick & Flint (1981) , using antiserum GJ137 (Sheldrick & Flint, 1985) . Extraction recoveries of 125I-labelled oxytocin added to plasma samples were 79-6 ± 1-5%, and sensitivity of the assay was 0-625 pg/ml plasma. Intra-and inter-assay coefficients of variation were 9-2 and 14-9% respectively.
DHKF-2a was measured as described by Mitchell et al (1975) after extracting acidified plasma with diethyl ether. Extraction recoveries were 82-9 + 3-2%; assay sensitivity was equivalent to 60 pg/ml plasma and intra-and inter-assay coefficients of variation were 7-9 and 100% respectively.
Values were corrected for extraction losses in all cases. All samples were assayed in duplicate. Statistics. Differences in progesterone between the groups of animals in Exp. 1 were assessed using a linear model that permitted calculation of statistical probabilities of (a) effects due to oestrogen treatment, (b) effects arising as a result of differences between individual animals in each group, (c) changes with time and (d) the interaction between oestrogen treatment and time. Changes with time and the interaction between treatment and time were not indepen¬ dent variables, because repeated measurements were made on the same ewes, and effects of these parameters were therefore tested using a conservative F-test (Gill, 1978) . The time at which concentrations of progesterone began to decline in oestrogen-treated animals was estimated by fitting linear and quadratic regression curves to segments of the data for each animal (Lerman, 1980) . Statistically significant peaks in secretion of DHKF-2a and oxytocin were identified using algorithms which assessed elevations of short duration in a series of observations by performing the following steps: (a) a base line was calculated representing the contribution of circadian rhythms or other long-term trends but not fluctuations of shorter duration; (b) a residual series that contained the secretory episodes, but not long-term trends, was calculated by subtracting base-line values; (c) the residual series was rescaled in terms of standard deviation units by dividing the rescaled values by an estimate of assay noise; (d) the peaks in the rescaled series were then identified by applying criteria of height and duration specified by user-defined cut-off points (G(n)). Peaks were thus identified as an indi¬ vidual subseries if they were elevated by G(n) standard deviation units (where values of G were selected by the user) for peaks of 1-5 datum points (n) in duration, (e) Steps (a)-(d) were repeated until 2 iterations produced the same values for peaks or until the preset limit, 6 iterations, was completed. Assay noise was estimated as a quadratic function of the quantity of hormone measured at each point (Merriam & Wächter, 1982) . By using duplicate values for each sample the mean and standard deviation were calculated; the entire series of standard deviations was plotted against the corresponding means and a quadratic model was fitted to relate the 2 parameters. Points in the series where hormone concentrations were below the lower limit of sensitivity of the assay were excluded from this calcula¬ tion. The numerical values for the quadratic (a), linear (b) and constant (c) terms of the model were: for DHKF-a, a = 000, b = 0Tl and c= -0-42; for oxytocin, a = 000, b = 008 and c = 0-22. The G(n) values were selected by an empirical approach using calibration data sets for each hormone. The following G(n) values were derived for both oxytocin and DHKF-2a: G(l) = 4-2, G(2) = 2-4, G(3) = 1 -6, G(4) = 1 0 and G (5) = 1 0. These calculations were carried out using a computer program, 'Pulsar' (Merriam et al, 1983 As expected from previous experience with the treatment used in this study (Hixon et ai, 1975) , premature luteolysis occurred after administration of oestrogen. Circulating concentrations of progesterone declined ( < 0-01) in all treated animals (Fig. 1) ; this decline began 420 +30 h after oestrogen treatment on Day 9. Progesterone levels were unchanged in control animals (Fig. 2f); concentrations of progesterone in this group at 84 and 96 h after treatment were 2-87 + 0-42 and 2-71 ±0-17 ng/ml respectively, compared to 0-37 + 0-14 and 0-45 + 0-19 ng/ml respectively in ewes receiving oestrogen. Oestrus was observed 67 + 9 h after first administration of oestrogen; in control animals the interval from vehicle treatment to oestrus was 187 + 9 h ( < 0-01). Episodes of secretion of DHKF-2a were observed in ewes that received oestrogen (Fig. 1) , the first peak occurring an average of 35 + 3 h after injection of oestrogen on Day 9. The mean number of peaks observed/ewe was 8+ 1 and the mean interval between peaks was 4-9 +0-2 h. There were no episodes of release of DHKF-2a in control ewes (Fig. 2g) although concentrations of DHKF-2a occasionally exceeded the lower limit of sensitivity of the assay.
Peaks in the secretion of oxytocin were observed in all ewes receiving oestrogen ( Fig. 1 ) and in 3 of the 5 vehicle-treated ewes (Figs 2a, b & c) . The interval of 26 + 3 h between the start of oestrogen treatment and the first peak in oxytocin was similar (P > 010) to that (29 + 9 h) for the 3 vehicletreated ewes in which at least one episode of oxytocin secretion was observed. Because more episodes of oxytocin secretion were observed during the sampling period in ewes treated with oestrogen than in the vehicle-treated animals (7+ 1 m3±1; P<001), the interval between peaks was shorter in the former group (7+1 vs 11 +2 h; < 0-05). The mean amplitude (increment above baseline) for peaks of oxytocin was 5-50+ 0-49 pg/ml in oestrogen-treated ewes and 4-87 + 0-98 pg/ml in controls (P>0T0). The first episode of oxytocin secretion after start of oestrogen treatment preceded (P<005) the first peak in DHKF-2a secretion (Fig. 1) (Table 1) . Episodes in the secretion of DHKF-2a exceeding the-criteria selected for peaks were not observed in ewes that received arachis oil or in oestrogen-treated ewes that were killed at 12 h (Table 1) .
When treated with arachis oil, uterine concentrations of oxytocin receptor were similar in animals killed on Days 9, 10 or 11 after oestrus (Fig. 3) . The administration of oestrogen increased (P<0-05) concentrations of oxytocin receptor in caruncular endometrium and myometrium at 12 h, and receptor concentrations were 4-fold higher in these tissues than in intercaruncular endo¬ metrium at this time. At 24 h oxytocin receptor concentrations were raised (P<005) in intercarun¬ cular tissue from oestrogen-treated ewes relative to those given vehicle, and receptor concentrations in all 3 uterine tissues from oestrogen-treated animals were higher at 36 and 48 h (P<001) than in control animals.
Effects of oestrogen treatment with and without oxytocin on incorporation of [3H]inositol into phosphatidylinositol and inositol phosphates are shown in Table 2 . Oestrogen treatment resulted in increased labelling of phosphatidylinositol, the maximum increase occurring after 48 h. Oestrogen alone had no effect on labelling of inositol phosphates. Oxytocin had no effect on incorporation of [3H]inositol into either phosphatidylinositol or inositol phosphates in the absence of oestrogen ( 2 = 0-43; > OT), but labelling of inositol phosphates was significantly enhanced by oxytocin in animals killed after treatment with oestrogen ( 2 = 9-7; < 0-01). (Walters et ai, 1984) . The coincidence of episodes of secretion of PGF-2a and oxytocin noted in treated ewes confirms observations made at spontaneous luteolysis (Fairclough et ai, 1980; Flint & Sheldrick, 1983) . Uterine concentrations of the oxytocin receptor observed here 48 h after oestrogen treatment were similar to those reported previously at oestrus (Roberts et ai, 1975; Sheldrick & Flint, 1985) except that the increase in the myometrium was more pronounced in the present study. Phosphoinositide turnover parameters were comparable to those reported for ovariectomized ewes treated with progestagen and oestrogen (Flint et ai, 1986) .
These findings raise the question of whether the induction of oxytocin receptor is responsible for the luteolytic action of administered oestrogen. Evidence that the receptor may play a role in this process includes the fact that oestradiol treatment causes secretion of PGF-2a ( Fig. 1 (Sharma & Fitzpatrick, 1974; Mitchell et ai, 1975; Roberts et ai, 1976) ; that immunization against oxytocin delays luteal regression (Sheldrick et ai, 1980; Schams et ai, 1983) and that uterine concentrations of the oxytocin receptor rise before spontaneous oestrus (Roberts et ai, 1975; Sheldrick & Flint, 1985) . The present results show that receptor concen¬ trations rise before any fall in the circulating concentration of progesterone in animals treated with oestrogen.
An increase in the responsiveness of the uterus to oxytocin, such as would be anticipated from the induction of the oxytocin receptor, may explain the enhanced sensitivity of the corpus luteum to PGF-2a in animals given oestrogen (Hixon et ai, 1975 (Hixon et ai, , 1983 . Prostaglandin F-2ct and its analogues are known to release oxytocin from the corpus luteum in ewes (Flint & Sheldrick, 1982; Heap et ai, 1986) ; administered PGF-2a may therefore stimulate production of additional endo¬ genous PGF-2a, as a result of release of luteal oxytocin and its effect on the uterus, in animals with a raised uterine oxytocin receptor level.
The fact that induction of the oxytocin receptor preceded luteolysis in animals treated with oestrogen raises the possibility that the rise in receptor at the end of the oestrous cycle (Roberts et ai, 1976 ) plays a causative role in spontaneous luteal regression. The interval between receptor induction and reduced progesterone observed here (30 h) is close to the sampling interval (24 h) used in earlier work, which could explain why it was not previously possible to dissociate these events (Sheldrick & Flint, 1985) . Gradual induction of the oxytocin receptor towards the end of the cycle may result from an increase in the sensitivity of the uterus to oestrogen (see McCracken et ai, 1984) . Evidence supporting this suggestion includes the prolongation of luteal function after destruction of ovarian follicles by X-irradiation in sheep and cattle (Karsch et ai, 1970; Hixon et ai, 1975; Villa-Godoy et ai, 1985) and the failure to identify any significant rise in circulating oestrogen secretion preceding luteal regression (Roberts et ai, 1975; Baird et ai, 1976) .
The mechanism by which oxytocin stimulates uterine prostaglandin synthesis has been sug¬ gested to involve increased hydrolysis of phosphatidylinositol phosphates with concomitant pro¬ duction of diacylglycerol, which is subsequently hydrolysed to release arachidonic acid (Flint et ai, 1986) . In the present work oestrogen treatment induced a marked increase in the ability of oxytocin to stimulate phosphoinositide turnover in vitro, which might be expected to result from an increase in oxytocin receptor concentration.
